News >

Ongoing Trials Hope to Move DLBCL Field Beyond R-CHOP

Jason Harris
Published: Friday, Sep 14, 2018

Thomas E. Witzig, MD
Thomas E. Witzig, MD
Cure rates in diffuse large B-cell lymphoma (DLBCL) remain relatively unchanged, even following therapeutic additions to the armamentarium and an improved understanding of disease biology.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication